Current through Register Vol. 35, No. 18, September 24, 2024
The intravenous therapy educational course curriculum shall
provide the doctor of oriental medicine, who successfully completes the course,
with the knowledge and skills defined in Section 10 of 16.2.18 NMAC and the
following specific knowledge and skills.
A. Pharmaceutical law: knowledge of
compatibility and sterile compounding procedures of authorized substances in
the intravenous therapy formulary in compliance with the compounding
requirements of the USP-797.
B.
Diagnostic phlebotomy knowledge of:
(1) and
skill in drawing blood for diagnostic purposes using appropriate aseptic
procedure;
(2) needles, lancets,
winged sets, syringes, vacutainer tubes, and other equipment used to draw blood
for diagnostic purposes; and
(3)
the various blood tests most relevant to the protocols being taught.
C. Intravenous therapy knowledge
of:
(1) and skill in the use of the equipment
used for intravenous infusions;
(2)
equipment used for an intravenous push;
(3) equipment used for injecting a bolus into
an infusion;
(4) local anatomy of
common infusion sites and skill in selecting an appropriate infusion
site;
(5) authorized substances
that are appropriate or not appropriate for intravenous infusion or injection
from the intravenous therapy formulary;
(6) concept and importance of osmolarity, pH
and skill in determining pH and calculating a given solution's osmolarity using
an osmolarity chart simple algebraic equation or computer software;
(7) prerequisite lab tests that should be
evaluated prior to initiating intravenous therapy of any kind;
(8) and skill in preparing and administering
an intravenous push, intravenous infusion and injecting a bolus into an IV
infusion; and
(9) possible
complications that could occur during an intravenous infusion or push and how
to identify, treat and manage these complications.
D. Oxidative medicine, photo-oxidation and
the use of oxygen therapeutically knowledge of:
(1) biochemistry of oxidative medicine
including the biological electron transfer sequence (BETS) oxidation and
reduction (redox) reactions;
(2)
and skill in the relevant clinical application and use of the authorized
substances in the intravenous therapy formulary;
(3) history, physics, equipment and
therapeutic use of ultraviolet blood irradiation (photoluminescence);
(4) history, physics, physiology and
therapeutic use, contraindications and safety considerations of hyperbaric
oxygen chamber therapy; and
(5)
blood borne pathogen training.
E. Detoxification and chelation therapy
knowledge of:
(1) diagnostic tools available
for determining and tracking the therapeutic elimination of body burden of
toxic elements including hair analysis, blood analysis and urinalysis with
provocation agents;
(2) how to
determine that the kidneys, colon and liver are functioning appropriately prior
to commencement of detoxification or chelation diagnostic and therapeutic
procedures;
(3) critical importance
of, and methods for, optimizing kidney and bowel function, and phase 1/phase 2
liver detox pathways, prior to and during detoxification or chelation therapy,
how to recognize when these systems are overburdened and what to do if they are
overburdened;
(4) biochemistry,
clinical use, and safety concerns relevant to all modes of administration of
the authorized substances used in detoxification or chelation therapy;
and
(5) how to explain to the
patient the purpose of the therapy, the expected outcome, alternatives and
possible complications of the therapy that could occur.